Radiopharm Theranostics Files 6-K Report
Ticker: RDPTF · Form: 6-K · Filed: Apr 28, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Radiopharm Theranostics filed a 6-K, standard reporting for foreign issuers.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on April 28, 2025, reporting information for the month of April 2025. The company is a foreign private issuer and is furnishing information to the SEC.
Why It Matters
This filing indicates ongoing reporting requirements for Radiopharm Theranostics as a foreign private issuer, providing updates to the SEC.
Risk Assessment
Risk Level: low — This is a routine reporting form for a foreign private issuer and does not contain specific financial or operational news that would inherently increase risk.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — Commission File Number
- April 2025 (date) — Reporting Period
- 20250428 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that provides information which the issuer makes or is required to make public pursuant to the laws of its home country, or which it furnishes or is required to furnish to its security holders.
What is the Commission File Number for Radiopharm Theranostics Limited?
The Commission File Number for Radiopharm Theranostics Limited is 001-41621.
What is the principal executive office address of Radiopharm Theranostics Limited?
The principal executive office address is Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Does Radiopharm Theranostics Limited file annual reports under Form 20-F?
Yes, the filing indicates that the registrant files or will file annual reports under cover of Form 20-F.
Is Radiopharm Theranostics Limited furnishing information under Rule 12g3-2(b)?
No, the filing indicates 'No' for furnishing information under Rule 12g3-2(b).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 28, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).